PL4252003T3 - Sposób analityczny dla glikokoniugatów z zastosowaniem systemu oznaczania immunologicznego na bazie kapilar - Google Patents

Sposób analityczny dla glikokoniugatów z zastosowaniem systemu oznaczania immunologicznego na bazie kapilar

Info

Publication number
PL4252003T3
PL4252003T3 PL21819229.2T PL21819229T PL4252003T3 PL 4252003 T3 PL4252003 T3 PL 4252003T3 PL 21819229 T PL21819229 T PL 21819229T PL 4252003 T3 PL4252003 T3 PL 4252003T3
Authority
PL
Poland
Prior art keywords
glycoconjugates
capillary
analytical method
based immunoassay
immunoassay system
Prior art date
Application number
PL21819229.2T
Other languages
English (en)
Inventor
Jan MANI
Michael Krieftewirth
Vera REBER
Joëlle BIANCHI
Annalisa PIANTA
Anish CHAKKUMKAL
Jan GRIJPSTRA
Diane KAGABO
Original Assignee
Janssen Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals, Inc. filed Critical Janssen Pharmaceuticals, Inc.
Publication of PL4252003T3 publication Critical patent/PL4252003T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561Immunoelectrophoresis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56916Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/245Escherichia (G)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
PL21819229.2T 2020-11-30 2021-11-30 Sposób analityczny dla glikokoniugatów z zastosowaniem systemu oznaczania immunologicznego na bazie kapilar PL4252003T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20210768 2020-11-30
PCT/IB2021/061115 WO2022113048A1 (en) 2020-11-30 2021-11-30 Analytical method for glycoconjugates using a capillary-based immunoassay system

Publications (1)

Publication Number Publication Date
PL4252003T3 true PL4252003T3 (pl) 2025-08-04

Family

ID=73646265

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21819229.2T PL4252003T3 (pl) 2020-11-30 2021-11-30 Sposób analityczny dla glikokoniugatów z zastosowaniem systemu oznaczania immunologicznego na bazie kapilar

Country Status (10)

Country Link
US (2) US20230349913A1 (pl)
EP (1) EP4252003B1 (pl)
JP (1) JP7495578B2 (pl)
CN (1) CN116406445B (pl)
CA (1) CA3203450C (pl)
ES (1) ES3030259T3 (pl)
HU (1) HUE071448T2 (pl)
IL (1) IL301880A (pl)
PL (1) PL4252003T3 (pl)
WO (1) WO2022113048A1 (pl)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5431793A (en) * 1994-07-29 1995-07-11 Beckman Instruments, Inc. Quantitative analysis of glycosylated hemoglobin by immunocappillary electrophoresis
PT1630168E (pt) 1997-08-27 2011-07-20 Novartis Vaccines & Diagnostic Compostos miméticos moleculares de péptidos de meningococos do serogrupo b
US6087128A (en) * 1998-02-12 2000-07-11 Ndsu Research Foundation DNA encoding an avian E. coli iss
US7179658B2 (en) * 2001-09-06 2007-02-20 Beckman Coulter, Inc. Particle based homogeneous assays using capillary electrophoresis with laser-induced fluorescence detection
FI20055417A0 (fi) * 2005-07-20 2005-07-20 Glykos Finland Oy Syöpäpesifiset glykaanit ja niiden käyttö
JP2007017445A (ja) 2006-07-20 2007-01-25 Ge Healthcare Bioscience Kk クロマトグラフィー用充填剤
US20090023156A1 (en) * 2007-07-20 2009-01-22 Voss Karl O Methods and reagents for quantifying analytes
LT2257307T (lt) 2008-02-20 2018-08-10 Glaxosmithkline Biologicals S.A. Biokonjugatai, gauti iš rekombinantinių n-glikozilintų baltymų iš prokariotinių ląstelių
US20180259508A1 (en) * 2008-12-10 2018-09-13 University Of Georgia Research Foundation, Inc. Glycan-specific analytical tools
CA2847621A1 (en) * 2011-09-06 2013-03-14 Glycovaxyn Ag Bioconjugate vaccines made in prokaryotic cells
JP6276427B2 (ja) 2014-02-24 2018-02-07 グリコヴァキシン アーゲー 新規の多糖及びその使用
TWI715617B (zh) 2015-08-24 2021-01-11 比利時商葛蘭素史密斯克藍生物品公司 對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物
WO2017130578A1 (ja) 2016-01-27 2017-08-03 和光純薬工業株式会社 前立腺癌の判定方法
CN107576733B (zh) * 2017-06-26 2020-11-24 复旦大学 一种基于糖蛋白非糖肽的质谱多反应监测定量糖蛋白方法
EP3655779A1 (en) * 2017-07-20 2020-05-27 CytomX Therapeutics, Inc. Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof
JP2019148564A (ja) 2018-02-28 2019-09-05 学校法人近畿大学 糖鎖解析方法、糖鎖解析システム、糖鎖解析用プログラム、及び糖鎖解析用キット
WO2019175145A1 (en) * 2018-03-12 2019-09-19 Janssen Vaccines & Prevention B.V. Vaccines against urinary tract infections
KR102719728B1 (ko) 2018-05-18 2024-10-18 후지필름 가부시키가이샤 전립선암을 판정하는 방법
WO2020191082A1 (en) * 2019-03-18 2020-09-24 Janssen Pharmaceuticals, Inc. Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereof
EA202192392A1 (ru) 2019-03-18 2022-02-09 Янссен Фармасьютикалз, Инк. Способы получения биоконъюгатов полисахаридных о-антигенов e.coli, их композиции и способы их применения

Also Published As

Publication number Publication date
HUE071448T2 (hu) 2025-08-28
CA3203450A1 (en) 2022-06-02
IL301880A (en) 2023-06-01
JP7495578B2 (ja) 2024-06-04
EP4252003B1 (en) 2025-03-05
EP4252003C0 (en) 2025-03-05
JP2023549573A (ja) 2023-11-27
US20230349913A1 (en) 2023-11-02
WO2022113048A1 (en) 2022-06-02
CN116406445A (zh) 2023-07-07
ES3030259T3 (en) 2025-06-27
US20250377362A1 (en) 2025-12-11
EP4252003A1 (en) 2023-10-04
CN116406445B (zh) 2024-07-12
CA3203450C (en) 2025-05-13

Similar Documents

Publication Publication Date Title
PT4264266T (pt) Método para detetar um analito
PL3742153T3 (pl) Sposób oznaczania ilościowego całkowitej zawartości saponin w próbce, w szczególności w próbce złożonej
PL4252003T3 (pl) Sposób analityczny dla glikokoniugatów z zastosowaniem systemu oznaczania immunologicznego na bazie kapilar
GB2603818B (en) A system and method for dry sorption
GB202012533D0 (en) System and method for automatic fleet partitioning
GB202300619D0 (en) System, method and device for monitoring wellbeing
EP4560320A3 (en) Two-dimensional lc-ms/ms systems
EP4529155A4 (en) SEARCH ASSISTANCE DEVICE, SEARCH ASSISTANCE SYSTEM, SEARCH ASSISTANCE METHOD, AND PROGRAM
GB202213272D0 (en) A system and method for identifying a cutscene
GB202417999D0 (en) System for the fully automated acquisition of tickets
EP4360252A4 (en) METHOD, APPARATUS AND SYSTEM FOR ZERO-DISCLOSURE JOINT PROOF OF POLYLITHIC SYNTAX KNOWLEDGE
ZA202204110B (en) Prospecting method for fluorite mines
GB2586469B (en) A method and system for parking
GB202418797D0 (en) Device, system, method
GB2626556B (en) System and method for inspecting a tubular
GB202302092D0 (en) Analytical method
GB202316489D0 (en) A risk analysis based system for infrastructure protection
GB202218773D0 (en) Analytical method
GB202020833D0 (en) The method for processing a blockchain-based transaction
GB202201800D0 (en) Analytical method
GB2623643B (en) A system for performing a measurement on a component
GB201917903D0 (en) Device, system and method for processing a sample
EP4583505A4 (en) INFORMATION PROCESSING DEVICE, IMAGING SYSTEM, INFORMATION PROCESSING METHOD AND PROGRAM
ZA202209918B (en) A method for analysis leadership approach
GB202319456D0 (en) Method and system for detecting an object by a vehicle